

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.34808022 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.34808022 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.29635806 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.29635806 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.29635806 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.29635806 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.29635806 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.29635806 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.24767425 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.08557292 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.87273956 |
| 12 | response to peptidoglycan (GO:0032494) | 5.40846512 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.28980250 |
| 14 | detection of other organism (GO:0098543) | 5.28740701 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.10950583 |
| 16 | detection of bacterium (GO:0016045) | 4.95715957 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92425070 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88772393 |
| 19 | cellular extravasation (GO:0045123) | 4.84619820 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.80322140 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.76665488 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.60811487 |
| 23 | microglial cell activation (GO:0001774) | 4.51184430 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.47833316 |
| 25 | neutrophil activation (GO:0042119) | 4.46926174 |
| 26 | leukocyte aggregation (GO:0070486) | 4.41502372 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.39070639 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35980378 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.27470809 |
| 30 | respiratory burst (GO:0045730) | 4.27323863 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.24651448 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.24617719 |
| 33 | response to host immune response (GO:0052572) | 4.24617719 |
| 34 | detection of biotic stimulus (GO:0009595) | 4.13930805 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 4.12469418 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.08584380 |
| 37 | positive regulation of mast cell activation (GO:0033005) | 4.07441770 |
| 38 | granulocyte activation (GO:0036230) | 4.03969852 |
| 39 | macrophage activation (GO:0042116) | 4.03431364 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 4.01243947 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.00617240 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.99785018 |
| 43 | neutrophil mediated immunity (GO:0002446) | 3.98130142 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95743421 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.90896427 |
| 46 | response to host (GO:0075136) | 3.90896427 |
| 47 | response to host defenses (GO:0052200) | 3.90896427 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74604737 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.71065973 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.70778037 |
| 51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.70612089 |
| 52 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.67555738 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64874346 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.63959378 |
| 55 | response to interleukin-15 (GO:0070672) | 3.60106816 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 3.54620495 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.54294308 |
| 58 | positive regulation of mast cell degranulation (GO:0043306) | 3.47478403 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.47478403 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.45429435 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.44708611 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.42960633 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.38750489 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.37926663 |
| 65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.35561289 |
| 66 | leukocyte degranulation (GO:0043299) | 3.28806885 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28584948 |
| 68 | B cell mediated immunity (GO:0019724) | 3.27642825 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 3.25493260 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25166919 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.25104332 |
| 72 | defense response to protozoan (GO:0042832) | 3.20580506 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 3.17292208 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15961512 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11343466 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 3.10877269 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09291391 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07754373 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.07740426 |
| 80 | type I interferon signaling pathway (GO:0060337) | 3.07740426 |
| 81 | activated T cell proliferation (GO:0050798) | 3.05814194 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05406347 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05125083 |
| 84 | response to type I interferon (GO:0034340) | 3.05118072 |
| 85 | positive regulation of tolerance induction (GO:0002645) | 3.03215164 |
| 86 | negative thymic T cell selection (GO:0045060) | 3.02703191 |
| 87 | dendritic cell migration (GO:0036336) | 2.99736526 |
| 88 | positive thymic T cell selection (GO:0045059) | 2.98914604 |
| 89 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97332918 |
| 90 | myeloid leukocyte activation (GO:0002274) | 2.97105309 |
| 91 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97100097 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95290297 |
| 93 | negative regulation of interleukin-6 production (GO:0032715) | 2.94398807 |
| 94 | germinal center formation (GO:0002467) | 2.94288817 |
| 95 | negative regulation of type 2 immune response (GO:0002829) | 2.93664578 |
| 96 | T cell migration (GO:0072678) | 2.93535567 |
| 97 | negative T cell selection (GO:0043383) | 2.93451367 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91848799 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.89467115 |
| 100 | neutrophil chemotaxis (GO:0030593) | 2.89417089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.45653044 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.92307167 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.40751179 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.89327243 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87171982 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.62566724 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44461075 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37988427 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01575472 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96435213 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.89123510 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88387316 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74917077 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.74754995 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68184448 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.67829667 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65187573 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63155191 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57339989 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49258861 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48651375 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.33075837 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.32531810 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.32256918 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25747799 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23859472 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22595178 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19273010 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16770508 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12229970 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09381008 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08838646 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07229097 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 2.01090586 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.98721680 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92628445 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88653654 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87825717 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86728218 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82695458 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80579656 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72713051 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70632663 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67758271 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66529273 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63974299 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.63660726 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60868669 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60765866 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51099203 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50557673 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49954982 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44930848 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43073645 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43025775 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42237556 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41272565 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40816018 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39379718 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38588402 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37807630 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37560504 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37048344 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35812328 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34074007 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31724281 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31722064 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30984526 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30272647 |
| 70 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27508337 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26194268 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24968606 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24653370 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19954716 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19670242 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18310163 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15226426 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15007889 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11026931 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07141013 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06040767 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05794708 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05752404 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05357704 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98144835 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97577372 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97324830 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96365901 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96334667 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95435582 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91637414 |
| 92 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.91301931 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85294693 |
| 94 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83737930 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83551499 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83225952 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81333418 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78285493 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74302009 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73533563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.11537326 |
| 2 | MP0003436_decreased_susceptibility_to | 4.32270959 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.13216909 |
| 4 | MP0003303_peritoneal_inflammation | 3.92290430 |
| 5 | MP0002419_abnormal_innate_immunity | 3.24462684 |
| 6 | MP0005671_abnormal_response_to | 2.99607522 |
| 7 | MP0009785_altered_susceptibility_to | 2.91504285 |
| 8 | MP0001800_abnormal_humoral_immune | 2.91423075 |
| 9 | MP0005025_abnormal_response_to | 2.90332266 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.87251761 |
| 11 | MP0006082_CNS_inflammation | 2.87035880 |
| 12 | MP0000685_abnormal_immune_system | 2.77228082 |
| 13 | MP0001790_abnormal_immune_system | 2.73170883 |
| 14 | MP0005387_immune_system_phenotype | 2.73170883 |
| 15 | MP0002723_abnormal_immune_serum | 2.60345942 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.53940997 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.52093139 |
| 18 | MP0001819_abnormal_immune_cell | 2.49676789 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.40706339 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.36283931 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.31389398 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.18252137 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.16223678 |
| 24 | MP0003828_pulmonary_edema | 2.10573640 |
| 25 | MP0008260_abnormal_autophagy | 2.09437200 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.97690284 |
| 27 | MP0002405_respiratory_system_inflammati | 1.96449797 |
| 28 | MP0002132_abnormal_respiratory_system | 1.93395469 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.91086903 |
| 30 | MP0002398_abnormal_bone_marrow | 1.90176198 |
| 31 | MP0000716_abnormal_immune_system | 1.86127274 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.77748044 |
| 33 | MP0009278_abnormal_bone_marrow | 1.76931349 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.75867103 |
| 35 | MP0004947_skin_inflammation | 1.63678154 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.59904176 |
| 37 | MP0009764_decreased_sensitivity_to | 1.58493373 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.57867984 |
| 39 | MP0002722_abnormal_immune_system | 1.55161441 |
| 40 | MP0003866_abnormal_defecation | 1.54441571 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.53976462 |
| 42 | MP0004883_abnormal_blood_vessel | 1.53667853 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.49450335 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.48479466 |
| 45 | MP0002429_abnormal_blood_cell | 1.47128468 |
| 46 | MP0008469_abnormal_protein_level | 1.44809220 |
| 47 | MP0005451_abnormal_body_composition | 1.43180382 |
| 48 | MP0000858_altered_metastatic_potential | 1.40210166 |
| 49 | MP0003075_altered_response_to | 1.39063113 |
| 50 | MP0004381_abnormal_hair_follicle | 1.38799724 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.37546703 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.37546703 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.36175919 |
| 54 | MP0001851_eye_inflammation | 1.32627623 |
| 55 | MP0004510_myositis | 1.30960752 |
| 56 | MP0003690_abnormal_glial_cell | 1.30839273 |
| 57 | MP0005310_abnormal_salivary_gland | 1.30320524 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.29394405 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.26696303 |
| 60 | MP0008004_abnormal_stomach_pH | 1.20260997 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.17534013 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.16533670 |
| 63 | MP0005164_abnormal_response_to | 1.16435941 |
| 64 | MP0005166_decreased_susceptibility_to | 1.10927672 |
| 65 | MP0000343_altered_response_to | 1.00108008 |
| 66 | MP0003448_altered_tumor_morphology | 0.93763832 |
| 67 | MP0001853_heart_inflammation | 0.92459713 |
| 68 | MP0009763_increased_sensitivity_to | 0.88616753 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 0.85861799 |
| 70 | MP0005390_skeleton_phenotype | 0.85822881 |
| 71 | MP0001663_abnormal_digestive_system | 0.84912371 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.81972543 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.79951487 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.78584404 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.78494293 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.77462111 |
| 77 | MP0002006_tumorigenesis | 0.75765007 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.75011199 |
| 79 | MP0003045_fibrosis | 0.71771982 |
| 80 | MP0000604_amyloidosis | 0.70660184 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.69472622 |
| 82 | MP0002009_preneoplasia | 0.68960612 |
| 83 | MP0000490_abnormal_crypts_of | 0.67101227 |
| 84 | MP0004130_abnormal_muscle_cell | 0.66086636 |
| 85 | MP0000249_abnormal_blood_vessel | 0.65845041 |
| 86 | MP0001873_stomach_inflammation | 0.64604515 |
| 87 | MP0003795_abnormal_bone_structure | 0.63944707 |
| 88 | MP0008874_decreased_physiological_sensi | 0.63145831 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.62093560 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59774040 |
| 91 | MP0005083_abnormal_biliary_tract | 0.58333582 |
| 92 | MP0003091_abnormal_cell_migration | 0.56773467 |
| 93 | MP0002933_joint_inflammation | 0.56115806 |
| 94 | MP0002133_abnormal_respiratory_system | 0.54185054 |
| 95 | MP0005388_respiratory_system_phenotype | 0.54185054 |
| 96 | MP0004484_altered_response_of | 0.52186753 |
| 97 | MP0002928_abnormal_bile_duct | 0.48776117 |
| 98 | MP0000920_abnormal_myelination | 0.48547863 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.48158546 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.47165497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.85176036 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.39270111 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.33954347 |
| 4 | Myositis (HP:0100614) | 6.00310003 |
| 5 | Orchitis (HP:0100796) | 5.70941536 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.68998718 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.46983156 |
| 8 | Optic neuritis (HP:0100653) | 5.46983156 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.24187331 |
| 10 | Stomatitis (HP:0010280) | 5.02803969 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.95608071 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.34823112 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.31424594 |
| 14 | Recurrent skin infections (HP:0001581) | 4.21123079 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.13809461 |
| 16 | Obstructive lung disease (HP:0006536) | 4.13809461 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.04424078 |
| 18 | Meningitis (HP:0001287) | 3.97481481 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 3.96396248 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.85481879 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81834563 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81834563 |
| 23 | Encephalitis (HP:0002383) | 3.81715738 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.76018666 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.72990092 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.70402126 |
| 27 | Urticaria (HP:0001025) | 3.57064276 |
| 28 | Gingivitis (HP:0000230) | 3.55680208 |
| 29 | Vasculitis (HP:0002633) | 3.54697126 |
| 30 | Gingival bleeding (HP:0000225) | 3.39468122 |
| 31 | Chest pain (HP:0100749) | 3.37441509 |
| 32 | Increased IgE level (HP:0003212) | 3.37373655 |
| 33 | Episodic fever (HP:0001954) | 3.31308179 |
| 34 | Amyloidosis (HP:0011034) | 3.30644362 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 3.29508825 |
| 36 | Hemoptysis (HP:0002105) | 3.14749749 |
| 37 | Arterial thrombosis (HP:0004420) | 3.12123071 |
| 38 | Peritonitis (HP:0002586) | 3.07876027 |
| 39 | Cellulitis (HP:0100658) | 3.07222835 |
| 40 | Epistaxis (HP:0000421) | 3.06542604 |
| 41 | Pulmonary infiltrates (HP:0002113) | 3.03803371 |
| 42 | Leukocytosis (HP:0001974) | 3.02548745 |
| 43 | T lymphocytopenia (HP:0005403) | 3.01183078 |
| 44 | Hypochromic anemia (HP:0001931) | 2.91340922 |
| 45 | Abnormality of T cell number (HP:0011839) | 2.88183074 |
| 46 | Recurrent viral infections (HP:0004429) | 2.86753928 |
| 47 | Petechiae (HP:0000967) | 2.83275359 |
| 48 | Anorexia (HP:0002039) | 2.80358057 |
| 49 | Pulmonary embolism (HP:0002204) | 2.73748027 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.69000075 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.58172314 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.54584808 |
| 53 | Abnormality of T cells (HP:0002843) | 2.51746873 |
| 54 | Increased IgM level (HP:0003496) | 2.51322475 |
| 55 | Purpura (HP:0000979) | 2.51269217 |
| 56 | Gangrene (HP:0100758) | 2.51029058 |
| 57 | Osteomyelitis (HP:0002754) | 2.50938838 |
| 58 | Pustule (HP:0200039) | 2.46326837 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.43039189 |
| 60 | Granulocytopenia (HP:0001913) | 2.40908276 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36950885 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.36886724 |
| 63 | Sepsis (HP:0100806) | 2.28588201 |
| 64 | Vertigo (HP:0002321) | 2.28464348 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.26399700 |
| 66 | Abnormality of the peritoneum (HP:0002585) | 2.24108422 |
| 67 | Microcytic anemia (HP:0001935) | 2.20654227 |
| 68 | Abnormality of the endocardium (HP:0004306) | 2.18254959 |
| 69 | Colitis (HP:0002583) | 2.17104996 |
| 70 | Increased serum ferritin (HP:0003281) | 2.13262797 |
| 71 | Glomerulopathy (HP:0100820) | 2.13230808 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.11014033 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.09651747 |
| 74 | Lymphopenia (HP:0001888) | 2.09450785 |
| 75 | Skin ulcer (HP:0200042) | 2.04972125 |
| 76 | Keratitis (HP:0000491) | 2.04888223 |
| 77 | Eosinophilia (HP:0001880) | 2.04275448 |
| 78 | Amaurosis fugax (HP:0100576) | 2.03970485 |
| 79 | Acne (HP:0001061) | 2.02437300 |
| 80 | Acute hepatic failure (HP:0006554) | 2.02231976 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.01016882 |
| 82 | Polyneuropathy (HP:0001271) | 2.00496866 |
| 83 | Loss of speech (HP:0002371) | 1.99160559 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95679823 |
| 85 | Hepatosplenomegaly (HP:0001433) | 1.95425475 |
| 86 | Viral hepatitis (HP:0006562) | 1.94039439 |
| 87 | Abnormality of the pericardium (HP:0001697) | 1.89653521 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89302307 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89302307 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89302307 |
| 91 | Slow saccadic eye movements (HP:0000514) | 1.88096068 |
| 92 | Chronic otitis media (HP:0000389) | 1.86750170 |
| 93 | Thrombophlebitis (HP:0004418) | 1.85843769 |
| 94 | Premature loss of primary teeth (HP:0006323) | 1.85258318 |
| 95 | Cheilitis (HP:0100825) | 1.84947732 |
| 96 | Skin rash (HP:0000988) | 1.83146521 |
| 97 | Polycythemia (HP:0001901) | 1.81657586 |
| 98 | Agammaglobulinemia (HP:0004432) | 1.81234240 |
| 99 | Recurrent pneumonia (HP:0006532) | 1.80723788 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74534841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.39943934 |
| 2 | MAP4K1 | 3.35534162 |
| 3 | BLK | 3.30440468 |
| 4 | IRAK4 | 3.05852811 |
| 5 | MAP2K3 | 3.01747338 |
| 6 | TYK2 | 2.96604040 |
| 7 | CSK | 2.89495019 |
| 8 | FES | 2.64338770 |
| 9 | ERN1 | 2.39582091 |
| 10 | PRPF4B | 2.31401344 |
| 11 | TNK2 | 2.19855734 |
| 12 | ZAP70 | 2.12503256 |
| 13 | GRK6 | 2.12185173 |
| 14 | FGR | 1.98433088 |
| 15 | EPHB1 | 1.96830459 |
| 16 | MAP3K3 | 1.89521082 |
| 17 | JAK3 | 1.84505283 |
| 18 | BTK | 1.83296468 |
| 19 | TXK | 1.78205839 |
| 20 | HCK | 1.76883285 |
| 21 | SYK | 1.74195364 |
| 22 | MAP3K14 | 1.66606878 |
| 23 | TAOK1 | 1.65354572 |
| 24 | MAP3K13 | 1.51335677 |
| 25 | CSF1R | 1.49104046 |
| 26 | IKBKE | 1.45128854 |
| 27 | JAK2 | 1.42153076 |
| 28 | LYN | 1.41906089 |
| 29 | SIK3 | 1.40888383 |
| 30 | TAOK3 | 1.39950865 |
| 31 | JAK1 | 1.39618097 |
| 32 | BMPR2 | 1.37642334 |
| 33 | MAP3K11 | 1.32789024 |
| 34 | YES1 | 1.31193174 |
| 35 | KSR2 | 1.30676937 |
| 36 | MAP3K1 | 1.24958168 |
| 37 | TBK1 | 1.22163647 |
| 38 | KIT | 1.18165606 |
| 39 | MATK | 1.17009214 |
| 40 | LCK | 1.16626087 |
| 41 | IRAK1 | 1.08036661 |
| 42 | MARK3 | 1.07546435 |
| 43 | TEC | 1.07112449 |
| 44 | IRAK2 | 1.04054424 |
| 45 | ITK | 1.02529508 |
| 46 | CDK19 | 1.01498806 |
| 47 | MARK2 | 0.99556186 |
| 48 | STK10 | 0.98004426 |
| 49 | PDK1 | 0.95544201 |
| 50 | IKBKB | 0.86975252 |
| 51 | PIK3CG | 0.86306700 |
| 52 | PDPK1 | 0.82937494 |
| 53 | SIK2 | 0.81293625 |
| 54 | PRKD2 | 0.78512274 |
| 55 | PTK6 | 0.77505760 |
| 56 | LRRK2 | 0.77364227 |
| 57 | MAP3K2 | 0.77038114 |
| 58 | TAOK2 | 0.73250314 |
| 59 | MAP3K6 | 0.72295254 |
| 60 | TGFBR2 | 0.70695070 |
| 61 | FYN | 0.68853732 |
| 62 | PTK2B | 0.67896673 |
| 63 | MAP3K7 | 0.67701650 |
| 64 | MAPK12 | 0.66762457 |
| 65 | MAPK7 | 0.64269176 |
| 66 | SGK3 | 0.61598996 |
| 67 | MAP2K4 | 0.59484844 |
| 68 | TRIB3 | 0.57802702 |
| 69 | MAP3K5 | 0.56747888 |
| 70 | STK11 | 0.55943179 |
| 71 | DYRK1B | 0.55775896 |
| 72 | CDC42BPA | 0.55228794 |
| 73 | GRK7 | 0.54071510 |
| 74 | FGFR3 | 0.52744644 |
| 75 | PRKCQ | 0.50472531 |
| 76 | TESK2 | 0.49498585 |
| 77 | RAF1 | 0.45938718 |
| 78 | SGK2 | 0.45369963 |
| 79 | KSR1 | 0.44519300 |
| 80 | HIPK2 | 0.43529327 |
| 81 | RPS6KL1 | 0.42194012 |
| 82 | RPS6KC1 | 0.42194012 |
| 83 | PIM1 | 0.42000915 |
| 84 | EPHA3 | 0.41832555 |
| 85 | NLK | 0.40911323 |
| 86 | RET | 0.40025141 |
| 87 | SIK1 | 0.39588656 |
| 88 | DAPK2 | 0.39142594 |
| 89 | MOS | 0.38754596 |
| 90 | SMG1 | 0.38643521 |
| 91 | CAMKK2 | 0.38459549 |
| 92 | FGFR4 | 0.37975011 |
| 93 | STK38 | 0.37144580 |
| 94 | RPS6KA6 | 0.35837099 |
| 95 | CAMKK1 | 0.33533860 |
| 96 | MAPKAPK2 | 0.32943379 |
| 97 | PRKD1 | 0.26797576 |
| 98 | WNK1 | 0.26010371 |
| 99 | PRKCZ | 0.24883946 |
| 100 | PRKCD | 0.24812933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.15473255 |
| 2 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.00188321 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86106733 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41049489 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.32137219 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.28710468 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25954831 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.25268030 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14398911 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11072799 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.10801033 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02607429 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.92426001 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90807004 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87650100 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75595036 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.73955662 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.73007300 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71536778 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.70493980 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69970371 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69557058 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63514229 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61781680 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59915165 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57071316 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53151176 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.52933090 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52821343 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.43346968 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37578094 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.37456943 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.35836423 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30635409 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30470669 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30305413 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30035985 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25854559 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24366677 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23725207 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20650790 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.15694516 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.13050271 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09280192 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07632897 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.03431254 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.99520060 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.96924957 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95456639 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93605302 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91727739 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90668027 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88639513 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.86429706 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84404879 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84338586 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81798743 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76446897 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75863374 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75783306 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75107151 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.75046764 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73175578 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72620729 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71668951 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70341609 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.70191345 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.70079360 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69684945 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65577660 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64746683 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64699077 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64199910 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63326618 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63178027 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61858107 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60637966 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60485024 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60255031 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59679934 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55177060 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54634454 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53335834 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52814788 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51451958 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51256066 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49982717 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49286294 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49130535 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48863906 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48393798 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46671622 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46276207 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.45411047 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45079879 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41200624 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40288169 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40163707 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38724012 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38690991 |

